These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33666402)

  • 1. The Efficacy and Safety of Lacosamide for Bipolar Depression: A 12-Week Open-Label Pilot Trial.
    Kishi T; Nomura I; Sakuma K; Okuya M; Oya K; Iwata N
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):204-206. PubMed ID: 33666402
    [No Abstract]   [Full Text] [Related]  

  • 2. The adverse-effect profile of lacosamide.
    Li J; Sun M; Wang X
    Expert Opin Drug Saf; 2020 Feb; 19(2):131-138. PubMed ID: 31914330
    [No Abstract]   [Full Text] [Related]  

  • 3. A trial of lacosamide for benign convulsions with gastroenteritis.
    Numoto S; Kurahashi H; Iwayama H; Okumura A
    Brain Dev; 2020 Aug; 42(7):551-554. PubMed ID: 32279898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real world, open label experience with lacosamide against acute painful oxaliplatin-induced peripheral neurotoxicity.
    Argyriou AA; Kalofonou F; Litsardopoulos P; Anastopoulou GG; Psimaras D; Bruna J; Kalofonos HP
    J Peripher Nerv Syst; 2020 Jun; 25(2):178-183. PubMed ID: 32277545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical efficacy experience of Lacosamide on sleep quality in patients with Nocturnal Frontal Lobe Epilepsy (NFLE).
    Mangiardi M; Alfano G
    Acta Biomed; 2018 Oct; 89(3):397-399. PubMed ID: 30333465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacosamide for SCN2A-related intractable neonatal and infantile seizures.
    Flor-Hirsch H; Heyman E; Livneh A; Reish O; Watemberg N; Litmanovits I; Ben Sason Lilli A; Lev D; Lerman Sagie T; Bassan H
    Epileptic Disord; 2018 Oct; 20(5):440-446. PubMed ID: 30361185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide induced Brugada I morphology in the setting of septicemia: A case report.
    Goodnough R; Badea A; Geier C; Lynch KL; LeSaint KT
    Medicine (Baltimore); 2021 May; 100(18):e25577. PubMed ID: 33950934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
    Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
    Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide in patients with intellectual disability and refractory epilepsy.
    Kleist A; Kerling F; Hamer H; Winterholler M
    Acta Neurol Belg; 2019 Sep; 119(3):423-430. PubMed ID: 30840220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine induced dress syndrome in bipolar disorder.
    Oriolo G; Brugués A; Pintor L; Goikolea JM
    Actas Esp Psiquiatr; 2017 May; 45(3):127-36. PubMed ID: 28594060
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of lacosamide in the treatment of neuropathic pain].
    Bermejo PE; Alba-Alcantara L
    Rev Neurol; 2013 Feb; 56(3):188-90. PubMed ID: 23359081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lacosamide associated with high-degree block in a patient with trigeminal neuralgia].
    Marin-Gracia M; Cantero-Lozano D; Garces-Anton E; Lopez-Bravo A; Garrido-Fernandez A; Navarro-Perez MP; Santos-Lasaosa S; Garces-Redondo M
    Rev Neurol; 2018 Mar; 66(6):189-192. PubMed ID: 29537058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longstanding Phenytoin Use as a Cause of Progressive Dyspnea.
    Walker A; Rupal A; Jani C; Al Omari O; Singh H; Patel D; Perrino C; McCannon J
    Chest; 2022 Feb; 161(2):e91-e96. PubMed ID: 35131079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial.
    Ferreira JA; Le Pichon JB; Abdelmoity AT; Dilley D; Dedeken P; Daniels T; Byrnes W
    Seizure; 2019 Oct; 71():166-173. PubMed ID: 31374487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
    Ben-Menachem E; Grebe HP; Terada K; Jensen L; Li T; De Backer M; Steiniger-Brach B; Gasalla T; Brock M; Biton V
    Epilepsia; 2019 Dec; 60(12):2437-2447. PubMed ID: 31755090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide in bipolar disorder: A 30-day comparison to a retrospective control group treated with other antiepileptics.
    Cuomo I; Piacentino D; Kotzalidis GD; Lionetto L; De Filippis S
    Psychiatry Clin Neurosci; 2018 Dec; 72(12):864-875. PubMed ID: 30251375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
    de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
    Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
    Schmitz B; Dimova S; Zhang Y; Chellun D; De Backer M; Gasalla T
    Epilepsy Res; 2020 Jan; 159():106220. PubMed ID: 31812127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
    Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
    Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.